MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED

Altre lingue Medical Developments International Limited

Azioni

MVP

AU000000MVP2

Mercato chiuso - Australian S.E. Altri mercati azionari 08:10:11 03/05/2024			Variaz. 5gg	Var. 1 gen.
0,47 ^AUD	+4,44%		-16,07%	-38,16%

29/04	Transcript : Medical Developments International Limited, Q3 2024 Earnings Call, Apr 29, 2024
29/02	Transcript : Medical Developments International Limited, H1 2024 Earnings Call, Feb 29, 2024

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Medical Developments International Limited Reports Earnings Results for the Half Year Ended December 31, 2023	28/02
Medical Developments International Limited(ASX:MVP) dropped from S&P/ASX Emerging Companies Index	18/09/23
Medical Developments International Limited Appoints Russell Basser to the Board Effective 1 September 2023	31/08/23
Medical Developments International Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31/08/23
Medical Developments International Limited Announces Resignation of David Williams from Board	18/04/23
Medical Developments International Searches for Partner to Commercialize Pain Relief Product in the US	11/04/23
Medical Developments International Limited(ASX:MVP) dropped from S&P/ASX All Ordinaries Index	20/03/23
Medical Developments International Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23/02/23
Medical Developments Stops Clinical Trial Preparation for Penthrox in China; Shares Rise 6%	18/01/23
Medical Developments International Limited Discontinues China Clinical Trials	17/01/23
Medical Developments International Limited Provides Revenue Guidance for the Year 2023	26/09/22
Medical Developments International Limited Announces Resignation of Max Johnston as Director, Effective 27 October 2022	26/09/22
Medical Developments International Limited(ASX:MVP) dropped from S&P Global BMI Index	19/09/22
Medical Developments International Limited Reports Earnings Results for the Full Year Ended June 30, 2022	26/08/22
Medical Developments International Limited Reports Earnings Results for the Full Year Ended June 30, 2022	26/08/22
Medical Developments International Sees Negative FY22 EBITDA, Launches Capital Hike	04/08/22
Medical Developments International Limited Provides Earnings Guidance for the Fiscal Year 2022 and Revenue Guidance for the Fiscal Year 2023	04/08/22
Medical Developments International Limited Appoints Tara Eaton as General Counsel and Company Secretary, Effective August 8, 2022	30/05/22
Medical Developments International Signs New Penthrox Licensing Agreement in Canada with New Partner Endo Ventures Limited	10/05/22
Medical Developments International Limited Announces Chief Financial Changes	05/05/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Medical Developments International Limited

Azioni

MVP

AU000000MVP2

Altre lingue

Filtri